✦ LIBER ✦

Recombinant interferon α2a is effective in the treatment of discoid and subacute cutaneous lupus erythematosus

✍ Scribed by J. THIVOLET; J.F. NICOLAS; J. KANITAKIS; S. LYONNET; B. CHOUVET

Book ID: 108661838
Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 247 KB
Volume: 122
Category: Article
ISSN: 0007-0963
DOI: 10.1111/j.1365-2133.1990.tb08290.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low-dose dapsone in the treatment of sub

Low-dose dapsone in the treatment of subacute cutaneous lupus erythematosus

✍ DAVID A. FENTON; MARTIN M. BLACK 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

CLOFAZIMINE (LAMPRENE) IN THE TREATMENT

CLOFAZIMINE (LAMPRENE) IN THE TREATMENT OF DISCOID LUPUS ERYTHEMATOSUS

✍ J. Krivanek; W. K. A. Paver; S. Kossard; G. Cains 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 308 KB

Intravenous immunoglobulin in the treatm

Intravenous immunoglobulin in the treatment of resistant subacute cutaneous lupus erythematosus: a possible alternative

✍ Christos E. Lampropoulos; Graham R. V. Hughes; David P. D’ Cruz 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 115 KB

Thalidomide in the treatment of sixty ca

Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus

✍ J. KNOP; G. BONSMANN; R. HAPPLE; A. LUDOLPH; D.R. MATZ; E.J. MIFSUD; E. MACHER 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB

A randomized trial comparing a pentavale

A randomized trial comparing a pentavalent antimonial drug and recombinant interferon-γ in the local treatment of cutaneous leishmaniasis

✍ G. Harms; A.K. Chehade; M. Douba; M. Roepke; A. Mouakeh; F. Rosenkaimer; U. Bien 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 340 KB

Recombinant interferon α-2A combined wit

Recombinant interferon α-2A combined with prednisone in metastatic renal-cell carcinoma: Treatment results, serum interferon levels and the development of antibodies

✍ Sophie D. Fosså; Gustav Lehne; Ragnhild Gunderson; Unni Hielmaas; Eduard E. Hold 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 375 KB 👁 1 views

Five partial responses were seen in 23 patients with metastatic renal-cell carcinoma (MRCC) receiving interferon-a 2a (IFN) + prednisone (P). Four of 24 subsequent patients responded to IFN + P (combined response rate 19%). The median response duration was 8 months (3 to 30 months). The one-year sur